Showing results (401-410 of 1,091) with videos related to

Sort By:
Pageof 110
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classificationWei Liu, Robert P Hasserjian, Ying Hu, et al.
Histopathology|December 2, 2016
Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literatureAlireza Salem, Sanam Loghavi, Joseph D Khoury, et al.
Journal of Clinical Pathology|June 26, 2014
Solitary plasmacytoma of the index fingerYahya Daneshbod, Pooria Ali Nowshadi, Shahrzad Negahban, et al.
Plos One|July 31, 2012
Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AMLZhuang Zuo, L Jeffrey Medeiros, Zhao Chen, et al.
Annals of Hematology|August 25, 2020
LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemiaWei Liu, Jan A Burger, Jie Xu, et al.
Archives of Pathology & Laboratory Medicine|June 13, 2024
Advancing Diagnostic Accuracy and Quality of Patient Care Through the Implementation of a Flow Cytometry Quality Assurance ProgramDylan Wang, Hong Fang, Chi Young Ok, et al.
American Journal of Clinical Pathology|May 19, 2005
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemiaC Cameron Yin, Armand B Glassman, Pei Lin, et al.
Annals of Diagnostic Pathology|April 1, 2019
Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phaseJuliana E Hidalgo-Lopez, Rashmi Kanagal-Shamanna, Steven Reyes, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid PopulationMark A Tesell, Caroline J Alper, Rachel Bacon, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemiaC Cameron Yin, Lynne V Abruzzo, Xiaoyan Qiu, et al.
Pageof 110